Before the beginning of the therapy, a clinician has to evaluate the extent and frequency of a proposed therapy and the patient’s risk factors. A complete cardiologic evaluation, electrocardiogram with evaluation of QTc, and an echocardiogram are the main tools of a preliminary evaluation of the candidates to chemotherapy. Additional investigations may be required in specific circumstances. Cancer patients during chemotherapy can develop several symptoms as dyspnea, palpitations, and chest pain whose differential diagnosis with other disorders is not always easy and requires specific investigation algorithms. The most widely used method for early detection of patients at high risk is echocardiography, but the measurement of cardio-specific biomarkers like troponin and NT-proBNP may be a valid diagnostic tool for early identification, assessment, and monitoring of cardiotoxicity. During therapy conduction, ECG and ECHO periodic evaluation associated to troponin and natriuretic peptides leads to different decision-making strategies.
|Title of host publication||Cardiac Management of Oncology Patients: Clinical Handbook for Cardio-Oncology|
|Publisher||Springer International Publishing|
|Number of pages||30|
|ISBN (Print)||9783319158082, 9783319158075|
|Publication status||Published - Jan 1 2015|
- Nuclear magnetic resonance
ASJC Scopus subject areas